BBlogFlow

Alternative Health Influencer Boasts That He’s Been Drinking From a Radioactive Jug for 250 Days Straight - Yahoo

·Oct 3, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

In 2026, anybody can cultivate a massive social media following doing anything their heart desires — and that's not necessarily a good thing. For a case in point, look no further than a recent Reel from holistic health influencer Matt Roeske. First spotted by the publication Reality Check, the clip features Roeske promoting radioactive water as a long-forgotten panacea, supposedly shut down by the "Rothschild medical system. "In his video, Roeske appears holding a "Revigator," an irradiated ceramic jug from the 1920s sold as a pseudoscientific miracle cure-all. In addition to carnotite — a bright-yellow rock known for its high uranium content — the Revigator contains a slew of chemicals like arsenic, lead, and vanadium, which is all stuff you shouldn't even shower with, let alone mix in your drinking water. "You see all that beautiful water in there? " Roeske asks while tilting the cistern toward the camera. "Perfectly harmless, you've just been lied to," he says before taking a huge mouthful of the stuff. "And it's delicious. And I've been drinking it for 250 days now.

This article is an excerpt. To read the full content, visit the original source. Yahoo

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·